Early Neurologic Symptom Onset
Placeholder: paresthesia and gait changes mark the first detectable nerve stress.
- Paresthesia: First symptom (Placeholder short note.)
- Gradual: Typical onset (Placeholder short note.)
- Peripheral: Nerve fibers affected (Placeholder short note.)
- Serum B12: Detection method (Placeholder short note.)
Subacute combined degeneration begins
Placeholder: dorsal column fibers are affected first.
Symptom recognition delay
Placeholder: vague symptoms often delay diagnosis.
Demyelination Progression
Placeholder: myelin sheath breakdown accelerates with time and severity.
- Methylmalonyl-CoA: Mechanism (Placeholder short note.)
- Time-dependent: Progression (Placeholder short note.)
- Slows / blocks: Conduction (Placeholder short note.)
- Yes: Reversible early (Placeholder short note.)
Myelin thinning mechanism
Placeholder: abnormal fatty acids disrupt myelin structure.
Conduction velocity decline
Placeholder: nerve signals slow as sheath degrades.
Treatment Initiation Timing
Placeholder: when B12 replacement starts strongly shapes the outcome.
- IM B12: Standard therapy (Placeholder short note.)
- Days–weeks: Response speed (Placeholder short note.)
- Full recovery likely: Early treatment (Placeholder short note.)
- Partial recovery: Late treatment (Placeholder short note.)
Replacement protocol
Placeholder: repeated injections restore serum B12 levels.
Timing determines outcome
Placeholder: earlier treatment start improves nerve recovery odds.
Reversibility Window Threshold
Placeholder: a critical duration separates reversible from fixed damage.
- ~3–9 months: Typical window (Placeholder short note.)
- Shortens window: Severity effect (Placeholder short note.)
- Intact vs degenerated: Axon status (Placeholder short note.)
- Early screening: Clinical priority (Placeholder short note.)
Threshold variability
Placeholder: window length varies with severity and individual factors.
Axonal versus myelin injury
Placeholder: axon loss, not just myelin loss, blocks recovery.
Permanent Damage Risk Beyond the Window
Placeholder: delayed treatment leaves scarred, non-recovering nerve segments.
- Gliosis: Scar tissue (Placeholder short note.)
- Capped: Recovery ceiling (Placeholder short note.)
- Common: Residual deficit (Placeholder short note.)
- Early screening: Prevention (Placeholder short note.)
Irreversible axonal loss
Placeholder: degenerated axons do not regenerate their original path.
Residual disability
Placeholder: patients may retain permanent gait or sensory deficits.